liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Activation of the CD95 pathway by anticancer drugs.
UNIV HEIDELBERG,CHILDRENS HOSP,D-6900 HEIDELBERG,GERMANY.
UNIV HEIDELBERG,CHILDRENS HOSP,D-6900 HEIDELBERG,GERMANY.
UNIV HEIDELBERG,CHILDRENS HOSP,D-6900 HEIDELBERG,GERMANY.
UNIV HEIDELBERG,CHILDRENS HOSP,D-6900 HEIDELBERG,GERMANY.
1996 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 88, no 10, 2641-2641 p.Article in journal, Meeting abstract (Refereed) Published
Place, publisher, year, edition, pages
1996. Vol. 88, no 10, 2641-2641 p.
National Category
Cancer and Oncology Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:liu:diva-87075ISI: A1996VT98302641OAI: oai:DiVA.org:liu-87075DiVA: diva2:584819
Available from: 2013-01-09 Created: 2013-01-09 Last updated: 2017-12-06

Open Access in DiVA

No full text

Authority records BETA

Los, Marek Jan

Search in DiVA

By author/editor
Los, Marek Jan
In the same journal
Blood
Cancer and OncologyBiochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 214 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf